Remdesivir

Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro. Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells.


Cat. No.: EX-A3265	Purity: >99%

	Chemical structure of Remdesivir

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	285	In-stock
500mg	385	In-stock
1g	585	In-stock
5g	985	In-stock
10g	1585	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	GS-5734
CAS No.	1809249-37-3
Purity	>99%
Formula	C27H35N6O8P
Mol Weight	602.576
State	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Wang M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. [2]. Agostini ML, et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. MBio. 2018 Mar 6;9(2). pii: e00221-18.
CoA	CoA of Remdesivir
HNMR	HNMR of Remdesivir
HPLC/LC-MS	LCMS/HPLC of Remdesivir

Smiles:	C[C@H](N[P@@](OC1=CC=CC=C1)(OC[C@H]2O[C@@](C#N)(C3=CC=C4C(N)=NC=NN43)[C@H](O)[C@@H]2O)=O)C(OCC(CC)CC)=O


		Search